Bone Biologics (BBLGW) Stock Analysis & Price (Updated Oct 12, 2026, 4:00 PM ET)
Updated Oct 12, 2026, 4:00 PM ET
- Closed at $7.70, +0.00% vs the prior close of $7.70.
- New SEC filings: 25-NSE (Oct 13, 2026).
- No new insider buys or sales reported since the prior session.
BBLGW ends flat (+0.0%) to $7.70. Closed at $7.70, +0.00% vs the prior close of $7.70. Day range $7.70β$7.70, opened at $7.70.
BBLGW daily analysis β what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 12, 2026 β BBLGW ends flat (+0.0%) to $7.70
- Closed at $7.70, +0.00% vs the prior close of $7.70. Day range $7.70β$7.70, opened at $7.70.
- Price is +25.1% vs its 50-day average ($6.15) and -50.3% vs its 200-day average ($15.50).
- 52-week range $3.50β$35.95; today's close sits at 13% of that range, 78.6% below the 52-week high.
Oct 9, 2026 β BBLGW jumps 17.8% to $7.70 on 20.1x normal volume
- Closed at $7.70, +17.83% vs the prior close of $6.53. Day range $5.39β$12.00, opened at $5.39.
- Volume was 13.40K shares, 20.1x its 50-day average of 666 β unusually heavy trading.
- Price is +24.2% vs its 50-day average ($6.20) and -50.5% vs its 200-day average ($15.55).
- 52-week range $3.50β$35.95; today's close sits at 13% of that range, 78.6% below the 52-week high.
Oct 8, 2026 β BBLGW ends flat (+0.0%) to $6.53, 3 down days in a row
- Closed at $6.53, +0.00% vs the prior close of $6.53. Day range $6.53β$6.53, opened at $6.53.
- Price is +4.6% vs its 50-day average ($6.25) and -58.2% vs its 200-day average ($15.62).
- 52-week range $3.50β$35.95; today's close sits at 9% of that range, 81.8% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 β BBLGW ends flat (+0.0%) to $6.53
- Closed at $6.53, +0.00% vs the prior close of $6.53. Day range $6.53β$6.53, opened at $6.53.
- Price is +3.5% vs its 50-day average ($6.31) and -58.4% vs its 200-day average ($15.70).
- 52-week range $3.50β$35.95; today's close sits at 9% of that range, 81.8% below the 52-week high.
Oct 6, 2026 β BBLGW slides 15.1% to $6.53
- Closed at $6.53, -15.13% vs the prior close of $7.70. Day range $6.53β$6.53, opened at $6.53.
- Volume was 1.00K shares, 1.5x its 50-day average of 648.
- Price is +2.4% vs its 50-day average ($6.38) and -58.6% vs its 200-day average ($15.77).
- 52-week range $3.50β$35.95; today's close sits at 9% of that range, 81.8% below the 52-week high.
Oct 5, 2026 β BBLGW jumps 39.2% to $7.70, a 1-month high on 10.4x normal volume
- Closed at $7.70, +39.24% vs the prior close of $5.53. Day range $4.40β$7.70, opened at $5.99.
- Volume was 5.60K shares, 10.4x its 50-day average of 536 β unusually heavy trading.
- Price is +19.5% vs its 50-day average ($6.44) and -51.4% vs its 200-day average ($15.85).
- 52-week range $3.50β$35.95; today's close sits at 13% of that range, 78.6% below the 52-week high.
- That makes 3 straight gains.
Oct 2, 2026 β BBLGW jumps 28.6% to $5.53 on 12.7x normal volume
- Closed at $5.53, +28.60% vs the prior close of $4.30. Day range $5.53β$7.99, opened at $5.99.
- Volume was 5.50K shares, 12.7x its 50-day average of 434 β unusually heavy trading.
- Price is -14.7% vs its 50-day average ($6.48) and -65.3% vs its 200-day average ($15.92).
- 52-week range $3.50β$35.95; today's close sits at 6% of that range, 84.6% below the 52-week high.
Oct 1, 2026 β BBLGW jumps 13.2% to $4.30
- Closed at $4.30, +13.16% vs the prior close of $3.80. Day range $4.30β$4.30, opened at $4.30.
- Volume was 500 shares, 1.1x its 50-day average of 436.
- Price is -34.5% vs its 50-day average ($6.56) and -73.1% vs its 200-day average ($16.00).
- 52-week range $3.50β$35.95; today's close sits at 2% of that range, 88.0% below the 52-week high.
Sep 30, 2026 β BBLGW slides 6.4% to $3.80, a 1-month low on 1.9x normal volume
- Closed at $3.80, -6.40% vs the prior close of $4.06. Day range $3.80β$4.28, opened at $4.28.
- Volume was 1.20K shares, 1.9x its 50-day average of 644 β unusually heavy trading.
- Price is -43.1% vs its 50-day average ($6.67) and -76.4% vs its 200-day average ($16.09).
- 52-week range $3.50β$35.95; today's close sits at 1% of that range, 89.4% below the 52-week high.
- That makes 11 straight losses.
Sep 29, 2026 β BBLGW ends flat (+0.0%) to $4.06, 10 down days in a row
- Closed at $4.06, +0.00% vs the prior close of $4.06. Day range $4.06β$4.06, opened at $4.06.
- Price is -39.9% vs its 50-day average ($6.76) and -74.9% vs its 200-day average ($16.18).
- 52-week range $3.50β$35.95; today's close sits at 2% of that range, 88.7% below the 52-week high.
- That makes 10 straight losses.
- SEC filings that day: 8-K.
BBLGW latest news & SEC filings
Every SEC filing by or about BBLGW in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 13, 2026 Β· Form 25-NSE β Notice that a security is being removed from exchange listing
Notice that a security is being removed from exchange listing
Sep 30, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 30, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 30, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 30, 2026 Β· Form 4 β Insider trade
Insider trade report (Form 4) β a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Sep 29, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 5.07 β Reported shareholder vote results.
Sep 16, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 3.01 β Stock exchange listing notice or transfer of listing.
Aug 28, 2026 Β· Form DEF 14A β Proxy statement
Proxy statement β agenda for the shareholder meeting (board elections, executive pay, votes)
Aug 18, 2026 Β· Form PRE 14A β Preliminary proxy statement
Preliminary proxy statement
Aug 14, 2026 Β· Form 10-Q β Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jun 30, 2026:
- Net income: -$773.70K (prior year -$740.52K) (loss widened vs Jun 30, 2025)
- Diluted EPS: -$0.43 (prior year -$1.33) (loss narrowed vs Jun 30, 2025)
Jul 24, 2026 Β· Form EFFECT β EFFECT filing
EFFECT filing
Jul 24, 2026 Β· Form 424B3 β Prospectus / supplement for an offering or resale
Prospectus / supplement for an offering or resale
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Jul 23, 2026 Β· Form 8-K β Major event / current report
Current report β a filing companies must make within 4 business days of a major event
- Item 7.01 β Released information under Regulation FD (e.g. a presentation or press release).
Jul 20, 2026 Β· Form DEFA14A β Additional proxy materials
Additional proxy materials
Jul 17, 2026 Β· Form S-3 β Shelf registration (S-3)
Shelf registration (S-3) β lets the company sell securities over time
An offering document: new shares or debt may be sold, which can increase the share count (dilution) or debt load. Size and terms are in the prospectus.
Things to know before you trade BBLGW
- How much it moves: over the last 20 sessions the average daily move was 8.35% (largest 39.2%). That is a volatile stock.
- Liquidity: about 1.70K shares (β$13.09K) trade per day on average. Thin volume can mean wider bid/ask spreads.
- 52-week position: $7.70 vs a range of $3.50β$35.95 (13% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 0 open-market buys, 0 sales.
- Latest filings: 8-K Sep 29, 2026; 8-K Sep 16, 2026; 10-Q Aug 14, 2026.
- Share count: 2.76M shares outstanding (Aug 14, 2026), +53.5% vs a year earlier β notable dilution.
- Listing: Nasdaq Β· industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies.
BBLGW market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 12, 2026 | 7.70 | 7.70 | 7.70 | 7.70 | 0 |
| Oct 9, 2026 | 5.39 | 12.00 | 5.39 | 7.70 | 13.40K |
| Oct 8, 2026 | 6.53 | 6.53 | 6.53 | 6.53 | 0 |
| Oct 7, 2026 | 6.53 | 6.53 | 6.53 | 6.53 | 0 |
| Oct 6, 2026 | 6.53 | 6.53 | 6.53 | 6.53 | 1.00K |
| Oct 5, 2026 | 5.99 | 7.70 | 4.40 | 7.70 | 5.60K |
| Oct 2, 2026 | 5.99 | 7.99 | 5.53 | 5.53 | 5.50K |
| Oct 1, 2026 | 4.30 | 4.30 | 4.30 | 4.30 | 500 |
| Sep 30, 2026 | 4.28 | 4.28 | 3.80 | 3.80 | 1.20K |
| Sep 29, 2026 | 4.06 | 4.06 | 4.06 | 4.06 | 0 |
| Sep 28, 2026 | 4.06 | 4.06 | 4.06 | 4.06 | 0 |
| Sep 25, 2026 | 4.06 | 4.06 | 4.06 | 4.06 | 0 |
| Sep 24, 2026 | 4.06 | 4.06 | 4.06 | 4.06 | 0 |
| Sep 23, 2026 | 4.06 | 4.06 | 4.06 | 4.06 | 0 |
| Sep 22, 2026 | 4.06 | 4.06 | 4.06 | 4.06 | 0 |
| Sep 21, 2026 | 4.06 | 4.06 | 4.06 | 4.06 | 0 |
| Sep 18, 2026 | 4.05 | 4.10 | 3.92 | 4.06 | 600 |
| Sep 17, 2026 | 5.70 | 5.70 | 4.22 | 4.30 | 1.00K |
| Sep 16, 2026 | 5.88 | 6.00 | 5.00 | 5.00 | 2.20K |
| Sep 15, 2026 | 7.30 | 7.48 | 6.10 | 6.10 | 3.00K |
About Bone Biologics
Bone Biologics (BBLGW) is listed on the Nasdaq and classified by the SEC under βOrthopedic, Prosthetic & Surgical Appliances & Suppliesβ. Its business address is in BURLINGTON, MA. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1419554.
BBLGW board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Siddhesh Rajendra Angle | Director | Sep 30, 2026 |
| Robert E. Gagnon | Director | Sep 30, 2026 |
| Phillip Terry Ii Meikle | Director | Sep 30, 2026 |
| Bruce Stroever | Director | Sep 30, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Jeff Frelick | Chief Executive Officer | Jan 21, 2026 |
| Deina H Walsh | Chief Financial Officer | Jan 21, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| No open-market insider buys or sales reported in the last 12 months. | ||||
BBLGW financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | β | $-3.11M | -2.65 | $-2.69M |
| Dec 31, 2024 | β | $-4.11M | -28.96 | $-4.12M |
| Dec 31, 2023 | β | $-8.95M | -34.01 | $-9.56M |
| Dec 31, 2022 | β | $-1.48M | -31.15 | $-3.57M |
| Dec 31, 2021 | β | $-1.61M | β | $-1.23M |
Latest balance sheet: total assets $4.44M, total liabilities $512.02K, cash $6.19M (as of Jun 30, 2026).
BBLGW earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| No 8-K earnings releases in recent filings. | ||
Related stocks Β· Orthopedic, Prosthetic & Surgical Appliances & Supplies
Intuitive Surgical (ISRG)Edwards Lifesciences (EW)Zimmer Biomet (ZBH)Align Technology (ALGN)Steris (STE)MSA Safety (MSA)Smith & Nephew (SNN)Enovis (ENOV)Establishment Labs (ESTA)Cadre (CDRE)
Popular today
Spdr S&P 500 Etf (SPY)Micron Technology (MU)Nvidia (NVDA)Meta Platforms (META)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Tesla (TSLA)Apple (AAPL)Intel (INTC)Microsoft (MSFT)Amazon (AMZN)
More on BBLGW
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 12, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.